Final Rules Broaden Pool for Stem Cell Research

Related Encyclopedia • Addison's Disease • Carcinoid Syndrome • Congenital Adrenal Hyperplasia • Cushing's Syndrome More... Related Healthscout Videos Kids Diagnosing Themselves Reversing Nerve Damage Monitoring Diabetes Patients And Doctors Discuss The I-Port More... Related Animations • Diabetes More... Related Drug Information • Actonel • Actos • Amaryl • Avandamet More... Related News Articles • People May Skip Soft Drinks Rather Than Pay More • Iodine Levels a Worry as Salt Use Declines • Gene Mutations Offer Clues to Autoimmune Disorders • Scientists Tease Out Links Between Diabetes, Cancer More...

Page:  << Prev | 1 | 2 | 3 | Next >>

Since the draft guidelines were issued by the NIH in April, "the question was what about the embryonic stem cells that have already been in use since 2001," said Paul R. Sanberg, director of the Center of Excellence for Aging and Brain Repair at the University of South Florida College of Medicine in Tampa. "There are many in those cases that didn't get informed consent."

"The more information we have about these cells that are used for research or potential treatment, the better off we'll be," Sanberg said. "It's important that there be documentation on tissue, on embryonic cells, that informed consent was received."

Different medical societies applauded the new guidelines, including the American Society for Reproductive Medicine (ASRM) and the Juvenile Diabetes Research Foundation (JDRF).

Text Continues Below

---

"The guidelines released today reflect the tremendous importance of embryonic stem cell research, while assuring that federal funds will only be available for use on stem cell lines derived under appropriate ethical supervision," ASRM spokesman Sean Tipton said in a prepared statement. "The scientific community is pleased that the policymaking is complete and is ready to get to work at learning how to tap the power of embryonic stem cells to relieve human suffering."

Alan J. Lewis, JDRF president and chief executive, "applauded" the new guidelines. "We particularly want to commend the NIH for including in the guidelines a provision under which existing stem cell lines derived in an ethically responsible manner would be eligible for federally funded research," he said in a news release. "This provision will ensure that a process is in place so researchers can build on the stem cell advancements made to date and accelerate research on cell lines with the greatest potential to facilitate treatment of the disease."

Page:  << Prev | 1 | 2 | 3 | Next >>